Liezl Gambe

XOMA Royalty (NASDAQ:XOMA) announced the amendment of its 2006 collaboration agreement with Takeda (NYSE:TAK), marking a strategic shift in the economics of their partnership.

The deal, announced on Dec. 30, 2025, will see Takeda regain the majority of XOMA Royalty's economics related to mezagitamab, a monoclonal antibody for inflammatory diseases.

InflaRx N.V. (NASDAQ:IFRX) provided an update on its Phase 3 study of vilobelimab in pyoderma gangrenosum (PG), outlining multiple data analyses after the trial was terminated earlier this year due to futility, following a recommendation from an Independent Data Monitoring Committee (IDMC).

HUTCHMED (NASDAQ:HCM) announced on Tuesday that Chinese regulators have accepted its New Drug Application (NDA) for savolitinib and granted it priority review, clearing a path for the drug to become the first selective MET inhibitor approved for gastric cancer in the region.

KKR (NYSE:KKR) and its affiliated Korean manager, Kreate Asset Management, have completed the purchase of the Cheongna Logistics Center in Incheon, marking the largest single-asset logistics transaction in South Korea’s history.

Bitcoin selling by long-term holders has slowed for the first time in months as Ether whales increase accumulation despite cautious market sentiment.

SEC Corporation Finance deputy director Cicely LaMothe is retiring after helping shape key crypto guidance during the agency’s recent policy shift.

Ripple executives say stablecoins have overtaken traditional payment rails, with transaction volumes surging as institutions and regulators embrace real-world adoption.

BlackRock’s BUIDL tokenised money market fund has paid out $100 million in Treasury yield dividends, highlighting institutional adoption of onchain finance.

A South Korean lawmaker is facing scrutiny after reports alleged he sought to help his son secure a job at a crypto exchange while questioning a rival firm.

Delixy Holdings (NASDAQ:DLXY) reported a contraction in top-line growth for the first six months of 2025, as the recently listed oil trader navigated a volatile energy market and narrowed its focus toward higher-margin operations.